The fetal heart anatomy is not routinely studied in the first trimester scan due to technical issues and time constraints. In some countries the gestational age for a legal termination is before 19 weeks and early diagnosis of major cardiac defects is of crucial importance. Our aim is to assess the feasibility of assessing fetal heart in pregnant women referred for first trimester screening, using high definition(HD)and B flow by an expert examiner. Methods: Four chamber(4C) and three vessel(3V)views of the fetal heart were obtained using HD and B flow by a certified examiner in pregnancies with a fetal Crown-rump length of 45-84 mm that had been referred for the first trimester screening. A GE RAB 4-8-D 3D/4D probe was used. The time for each method was recorded using the time displayed at the top of ultrasound images. If the screening was low risk and the 4C and 3V views were normal the mother was scheduled for a routine anomaly scan. All fetuses with NT>3 mm, high risk results, or suspected heart diseases were referred for an amniocentesis and a repeat scan at 15+ weeks. All suspected cardiac defects were confirmed by a cardiologist. Results: 365 fetuses were examined between December 2016 and March 2017.Successful assessment was done in 365 and 355 cases and both views were assessed confidently within a range of 2-128(mean 20.4) and 5-154 (mean 22.3) seconds, using HD and B flow respectively. Student pooled t-test did not show significant differences between the means of time needed for the two methods(P=0.874).Using the same test, we failed to prove a statistically significant correlation between body mass index of the mothers and failure of the imaging(in this case B flow)(P=0.806).This can be related to the sample size as we observed 1.6 higher BMI values in the failed cases. Conclusions: An expert examiner can do a fetal cardiac scan during the first trimester screening with HD or B flow in a reasonable length of time and at no extra cost. These findings should be verified by follow up exams and birth outcomes later on.
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Objectives: This study aims to discuss the application value of STIC technology for the prenatal diagnosis of abdominal vascular malformations, and increase the prenatal diagnosis rate. Methods: From March 2015 to September 2016, in case of suspicious abnormalities, abdominal blood flow was evaluated with STIC mode. Results: 17 cases were diagnosed with different abdominal vascular malformations, including six cases with portosystemic shunt, three cases with right heterogeneous malformations, six cases with infracardiac pulmonary vein malformations, and two cases with hepatic arteriovenous fistula. The distribution of fetal abdominal vessels is complex, and there is a significant difference from adults. For example, in adults, the portal venous trunk branches out the left and right portal vein in the liver, while the left portal veins of the fetuses receive blood supply from the umbilical and the right portal veins receive blood supply from both the left portal vein and portal venous trunk. Due to the complexity of fetal abdominal blood vessels, physicians for ultrasound examinations have difficulty in constructing the spatial structure with a few cross-sectional images. Hence, prenatal diagnosis is more difficult. Through STIC technology, the spatial image of blood flow in the interested areas can be established more clearly and can increase the prenatal diagnosis rate. Conclusions: Based on the familiarisation of the abdominal vascular anatomy of fetuses, the application of STIC blood flow imaging can increase both prenatal diagnosis rate and accuracy rate for abdominal vascular malformations.
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Prenatal diagnosis of aberrant right subclavian artery (ARSA) in unselected population: our own experience R.S. Bataeva Objectives: The aim of our study was to analyses all cases with aberrant right subclavian artery (ARSA) and its association with chromosomal and other congenital malformations. Methods: 2863 fetuses between 12 and 34 weeks were examined by ultrasound in our centre between January 2015 and March 2017 by one examiner. ARSA was assessed in the axial plane on the level of three vessels and trachea view. Results: ARSA was identified in 33 fetuses. ARSA was an isolated finding in 13 (39%) fetuses and non-isolated in 20 (60%) fetuses. In 9 (27%) of these 33 cases ARSA associated with congenital cardiac anomalies such as AVSD, coarctation of aorta, vascular ring, right aortic arch, HLHS, bilateral superior vena cava and tetralogy of Fallot (2). Additional ultrasound findings such as an occipital encefalocele, hemivertebra (2 cases), diastematomyelia, partial agenesis of corpus callosum, cavum velli interposity, tricuspid regurgitation, single umbilical artery, large NT (3 cases), abnormal hands, retrograde ductus venosus blood flow were present in 14 (42%) fetuses. 5 (15%) of these of 33 were aneuploidies: Trisomy 21 was diagnosed in 4 fetuses, Trisomy 18 in 1 fetus. 22q11 microdeletion was detected in 1 fetus. All women with isolated ARSA were recommended to have a non-invasive prenatal diagnostic test. No cases with Down syndrome were detected in all 13 fetuses with isolated ARSA. Conclusions: Isolated ARSA does not seem to be associated with a significantly increased risk of aneuploidy, however using of a non-invasive diagnostic test might be discussed. When ARSA is identified a detailed anatomy scan should be recommended. An invasive procedure with genetic diagnosis should be discussed when additional ultrasound abnormalities or risk factors for aneuploidy are found. 
